ReviewFrontiers in oncology2021
KRAS-Mutant Non-Small Cell Lung Cancer: An Emerging Promisingly Treatable Subgroup.
Mingying Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
this papercites it
ReviewFrontiers in oncology2021
Mingying Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.